Tranexamic Technologies Joins Johnson & Johnson Innovation, JLABS

Tranexamic Technologies is delighted to share the exciting news of its recent acceptance into the esteemed Johnson & Johnson Innovation, JLABS program. This milestone partnership signifies a significant leap forward in our mission to drive healthcare innovation worldwide. As a resident company of JLABS, we are poised to leverage the extensive resources and collaborative opportunities offered by this premier life science incubator network.

Through JLABS' global ecosystem of open innovation, we are empowered to accelerate the development and delivery of life-enhancing health and wellness solutions to patients across the globe. This collaboration aligns perfectly with our commitment to pioneering advancements in pharmaceuticals, medical devices, consumer healthcare, and health technology sectors. Together with JLABS, we look forward to making a meaningful impact in improving healthcare outcomes and enhancing the quality of life for individuals worldwide.